Friday, Sep 12, 2014
Prager H2: Lee sitting in for Dennis. The FDA is a huge bureaucracy that should be challenged over their old school ideas for not allowing certain drugs on the market. Specifically drugs that would help specific individuals. Ed Levitt told his story about the drug Irisa, which helped him heal from lung cancer. Peter Huber, fellow at Manhattan Institute, discusses what Ed’s story means for the FDA. Dr. Joseph Golfo wrote Innovation Breakdown: How The FDA and Wall Street Cripple Medical Advances, reviewed by Alex Tabarrok.